Kronos Bio Inc Ordinary Shares KRON

Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover KRON, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
—
Day Range
—–—
52-Week Range
—–—
Bid/Ask
— / —
Shares Outstanding
60.97M
Market Cap
—
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
5.78
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
8

Valuation

Metric
KRON
Price/Earnings (Normalized)
—
Price/Book Value
0.67
Price/Sales
5.78
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
KRON
Quick Ratio
12.66
Current Ratio
12.93
Interest Coverage
—
Quick Ratio
KRON

Profitability

Metric
KRON
Return on Assets (Normalized)
−26.67%
Return on Equity (Normalized)
−36.13%
Return on Invested Capital (Normalized)
−33.51%
Return on Assets
KRON

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|ZpQrRbqLOCK|S&g<$$139B
Moderna Inc
MRNA
LOCK|s?VkP^LOCK|c%#$103B
Regeneron Pharmaceuticals Inc
REGN
LOCK|<%^b>!LOCK|cgLD$96B
argenx SE ADR
ARGX
LOCK|P&h$GZMLOCK|?C$57B
BeOne Medicines Ltd ADR
ONC
LOCK|<z$@!%tLOCK|ht$45B
Royalty Pharma PLC Class A
RPRX
LOCK|c%><kDLLOCK|@mP&v$30B
Incyte Corp
INCY
LOCK|M?@y&yLOCK|Cy>$25B
BioNTech SE ADR
BNTX
LOCK|ZKxf@nbLOCK|p?$22B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|yQyZ#JLOCK|q&^@$22B
BridgeBio Pharma Inc
BBIO
LOCK|?B%zFwLOCK|MD$15B

Sponsor Center